Advertisement

Topics

Companies Related to "Open-label, Randomized Trial to Determine the Effect of Icodextrin Versus Dextrose (Dianeal 2.5%) in HOMA IR" [Most Relevant Company Matches] RSS

08:15 EDT 18th October 2018 | BioPortfolio

Here are the most relevant search results for "Open-label, Randomized Trial to Determine the Effect of Icodextrin Versus Dextrose (Dianeal 2.5%) in HOMA IR" found in our extensive corporate database of over 50,000 company records.

Showing "Open label Randomized Trial Determine Effect Icodextrin Versus" Companies 1–25 of 1,600+

Relevant

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...


Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis. The Company has two broad platform technologies: dendritic cell-based vaccines and therapeutic antibodies. The Company is focusing on development ...

Soligenix, Inc.

Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec(®) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute ...


CLINICAL SYSTEMS, INC

Clinical Systems, Inc. specializes in providing products and services to the pharmaceutical industry. We are focused on the needs of those individuals involved with Clinical Trial Materials. Our products and services are summarized below: SERVICES CLINSERV™ CONTRACT CLINICAL LABEL GENERATION SERVICECLINSERV™ is a contract clinical label generation service that provides you with ready to apply...

Adeona Pharmaceuticals, Inc.

Adeona (AMEX: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Adeona's primary strategy is to in-license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to an inflection point in valuation resulting in a significant development and marketing collaboration. Trimesta (estriol) ...

BioTechNews Denmark

TopoTarget and CuraGen Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for MesotheliomaTopoTarget A/S and CuraGen Corporation announced today the initiation of patient dosing in a Phase II clinical trial evaluating the activity of PXD101, a small molecule histone deacetylase (HDAC) inhibitor, for the treatment of mesothelioma. This trial is being sponsored by the National ...

Iinvivodata

invivodata is the worldwide leader in capturing clinical trial data of the highest integrity directly from patients. With a unique combination of scientific, technological, and regulatory expertise, invivodata has pioneered the evolution of the electronic Patient Reported Outcomes (ePRO) industry and continues to provide innovative methods that make it easy for clinical trial sponsors to attain th...

Tricida, Inc.

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. Tricida has successfully...

GWC Technologies

GWC Technologies is the emerging leader in “label-free” detection systems for life science research. The company develops, manufactures and markets label-free detection systems for:Detection of biomolecular interactions, and Measurements of surface film thickness. GWC's technology platform is centered on Surface Plasmon Resonance (SPR), an electro-optical effect that facilitates measurements o...

Sangamo BioSciences, Inc.

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in a Phase 2b clinical trial for evaluation of safety and clinical effect in patients with diabetic neuropathy and a Phase 2 trial in ALS. Sangamo also has two Phase 1 clinical tri...

Tharo Systems, Inc.

Tharo Systems, Inc. has been a world leader in the Automatic Identification industry since 1982. Tharo is the author of EASYLABEL® software, the best selling, most powerful label design software on the planet. There are over 78,000 copies running in almost every country in the world. Tharo has extended its expertise into the development of the Heavy Duty H-Series and Value Priced V-Series printer...

Off-Label Ltd

Off-label.com provides biopharma with a low cost/low risk route to product development. Since launch in 2004 off-label.com has now screened 2 million Medline citations.Finding new uses for existing drugs makes commercial sense for big and small pharma says NATURE report - next decade will see the growth of a new business model (Nat Rev Drug Discov 2005 4(6) 446)

Cypress Bioscience

We are committed to being the innovator and leader in providing products for the treatment of patients with Functional Somatic Syndromes, such as Fibromyalgia Syndrome, or FMS, and other central nervous system disorders. Specifically, our strategy involves acquiring or in-licensing central nervous system, or CNS, active compounds and developing them for novel and typically underserved indications....

Callisto Pharmaceuticals, Inc.

Callisto Pharmaceuticals, Inc., is a publicly traded biotechnology company on the American Stock Exchange (AMEX:KAL) and Frankfurt Exchange (CA4). Callisto's primary focus is the clinical development of two drugs to treat cancer, L-Annamycin for relapsed leukemia and Atiprimod for relapsed multiple myeloma (MM) and bone resorption. L-Annamycin, a drug from the anthracycline family, earlier complet...

ClinicalStudyDataRequest.com

ClinicalStudyDataRequest.com is the industry leader in global clinical trial data transparency. Its multi-sponsor Request System provides a secure process for researchers to request access to global clinical trial data through a publicly available website. An Independent Review Panel and process overseen by the Wellcome Trust review data requests received ...

eClinicalHealth Limited

Headquartered in Scotland, eClinicalHealth Limited, developers of the ClinpalTM remote research platform, was founded in 2012 to provide innovative clinical trial solutions. The company is committed to leading open and collaborative innovation discussions about patient-centric clinical trial processes and technology with pharmaceutical companies, CROs and ...

eClinicalHealth

Headquartered in Scotland, eClinicalHealth Limited, developers of the revolutionary Clinpal patient engagement platform, was founded in early 2012 to provide innovative clinical trial solutions. The company is committed to leading open and collaborative innovation discussions about remote clinical trial processes and technology with pharmaceutical compa...

YORK Label

Omaha, NE based YORK Label is a leading provider of high quality, innovative labeling and package decoration solutions to global consumer products, wine and spirits, pharmaceutical and, food and beverage companies. YORK Label has production facilities throughout North America and a joint venture in Chile. The company employs more than 700 dedicated associates. For more information please visit ww...

Eminent effect

The eminent effect is a consultancy aiming to stand out from the crowd in tackling many of today’s people and business challenges. The company offers organisation specific training, development, sales/marketing and interim management solutions not off the shelf packages.Primarily working within the NHS, Pharmaceutical and Biotechnology sectors, the eminent effect personnel can offer experience g...

Open Source Initiative (OSI)

Open Source Initiative (OSI) is a non-profit corporation dedicated to managing and promoting the Open Source Definition for the good of the community, specifically through the OSI Certified Open Source Software certification mark and program. You can read about successful software products that have these properties, and about our certification mark and program, which allow you to be confident tha...

Honest Label Foods

Honest Label Foods was created in 2011 by entrepreneur and nutrition crusader, Taylor Ernst, based on the concept of transparency in food labeling and the belief that all consumers have a right to know about the foods they put in their body. The Honest Label Foods Scanner allows shoppers to scan barcodes of food products in the grocery store to receive ins...

Open Health Tools

Open Health Tools is a nonprofit organization that promotes the availability of open technologies in healthcare worldwide. With over 60 members, OHT is transforming the global market for healthcare IT in ways that make access to high quality healthcare easier and more affordable. Open Health Tools develops and uses open source software code and implements ...

DOR BioPharma, Inc.

DOR BioPharma, Inc. (DOR) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DOR's lead product, orBec(R) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of GI GVHD, a comm...

Open eHealth Foundation

Open eHealth Foundation (OeHF), launched at HIMSS 08, uses existing open source projects for developing a platform on which its members and other providers can create open source components that are made available free of charge, including reference implementations to obtain high semantic interoperability based on open standards. Open eHealth Foundation will not develop any new interoperabilit...

Protalex, Inc.

Protalex, Inc. is a clinical stage biopharmaceutical company that is developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including but not limited to, rheumatoid arthritis. Protalex’s lead product PRTX-100, which is formulated with a highly-purified form of staphylococcal protein A, has completed a Phase 1b...


More From BioPortfolio on "Open-label, Randomized Trial to Determine the Effect of Icodextrin Versus Dextrose (Dianeal 2.5%) in HOMA IR"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks